John Berdahl, MD
Show Description +
With many patients who suffer from presbyopia frustrated with their need for reading glasses, a safe and effective topical solution presents an exciting opportunity. John Berdahl, MD, discusses the promise shown from the development of Orasis Pharmaceuticals' novel presbyopic therapy, and, the importance of adding this new, non-surgical presbyopia-correcting tool to your toolkit.
Posted: 11/23/2021
John Berdahl, MD
With many patients who suffer from presbyopia frustrated with their need for reading glasses, a safe and effective topical solution presents an exciting opportunity. John Berdahl, MD, discusses the promise shown from the development of Orasis Pharmaceuticals' novel presbyopic therapy, and, the importance of adding this new, non-surgical presbyopia-correcting tool to your toolkit.
Posted: 11/23/2021
About Orasis Pharmaceuticals
ORASIS (OR-uh-sis) Pharmaceuticals is an emerging ophthalmic pharmaceutical company, with offices in the US and Israel, focused on developing an innovative solution for the treatment of presbyopia symptoms. Orasis’ novel proprietary formulation of low dose pilocarpine and a proprietary vehicle was purposefully designed with the patient in mind to achieve an optimal balance among efficacy, safety, and comfort.
The name Orasis has its roots in the Greek language, where it carries a literal translation of “good vision or sight.” Beyond this, however, as good vision in its positive mental/philosophical meaning — and this speaks to our aspiration as a company to develop pharmaceutical drugs that improve vision and quality of life for millions of people around the world.
Visit us online: orasis-pharma.com
Follow Orasis Pharmaceuticals